Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | BCHE | P06276 | 2/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28445202 | 0.98 | ALDH1A1 (0.62) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL8258700 | 0.85 | TSHR (0.48) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL4320077 | 0.85 | GAA (0.50) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL4318702 | 0.82 | KMT2A (0.51) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL588715 | 0.81 | ALDH1A1 (0.68) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL2449608 | 0.81 | ALOX15 (0.68) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL11313942 | 0.80 | LMNA (0.81) | ALDH1A1BCHEPTGS2LMNAADORA3 | |
| Hydrochloric Acid SCHEMBL28311112 | 0.79 | ALOX15 (0.66) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL27660283 | 0.79 | ALOX15 (0.66) | ALDH1A1ALOX15BCHEPTGS2LMNA | |
| SCHEMBL4321369 | 0.78 | FPR2 (0.49) | ALDH1A1ALOX15BCHEPTGS2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118026938-B | Pyrazolone ester compound and electrochemical synthesis method thereof | 江西本草天工科技有限责任公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118026938-A | Pyrazolone ester compound and electrochemical synthesis method thereof | 江西本草天工科技有限责任公司 | 2024-05-14 | — | — | CN | claimed |
| US-9770514-B2 | Tamper-resistant pharmaceutical dosage forms | ExxPharma Therapeutics LLC (US) | 2017-09-26 | — | — | US | claimed |
| CN-104825397-A | Controlled release delivery device containing organosol coating | ISA ODIDI | 2015-08-12 | — | — | CN | claimed |
| US-20150064250-A1 | Tamper-Resistant Pharmaceutical Dosage Forms | ExxPharma Therapeutics LLC (US) | 2015-03-05 | — | — | US | claimed |
| CN-102014625-A | Novel formulations for the treatment of migraine | ZOGENIX INC | 2011-04-13 | — | — | CN | claimed |
| EP-4168092-B1 | BALLOON CATHETER WITH PRECISION DRUG-ELUTING CAPABILITY | BARD INC C R (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | REGENERON PHARMA (US) | 2026-04-09 | — | — | US | disclosed |
| US-12472241-B2 | Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors | REGENERON PHARMACEUTICALS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-12458392-B2 | Scoring balloon with translating scoring wires | C.R. BARD, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-12167883-B2 | Medical device including expandable muscle polymer | BARD PERIPHERAL VASCULAR, INC. (US) | 2024-12-17 | — | — | US | disclosed |
| CN-118026938-B | Pyrazolone ester compound and electrochemical synthesis method thereof | 江西本草天工科技有限责任公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118026938-A | Pyrazolone ester compound and electrochemical synthesis method thereof | 江西本草天工科技有限责任公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2004011055-A2 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY | SCIMED LIFE SYSTEMS, INC. (US) | 2004-02-05 | — | — | WO | disclosed |
| US-20030224033-A1 | Implantable or insertable medical devices for controlled drug delivery | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-04 | — | — | US | disclosed |
| CN-1122719-C | Modified biological material | IMUTRAN LTD (GB) | 2003-10-01 | — | — | CN | disclosed |
| CN-1148891-A | Method of quantifying cholesterol in low-density of very-low-density lipoprotein | KYOWA MEDEX CO LTD (JP) | 1997-04-30 | — | — | CN | disclosed |
| CN-1051199-A | MODIFIED BIOLOGICAL MATERIAL | IMUTRAN LTD (GB) | 1991-05-08 | — | — | CN | disclosed |
| US-4499104-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTICONVULSANT AGENTS | FARMATIS S.R.L. (IT) | 1985-02-12 | — | — | US | disclosed |
| US-4115096-A | Dihydropyrazolone herbicide | FMC CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | ALOX15, ALOX15B, ALOX5 | ALDH1A1 900/4885ALOX15 1/4885BCHE 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.